2021, Number 1
Rev Mex Urol 2021; 81 (1)
Science in the face of a crisis
Guzmán-Esquivel J
Language: Spanish
References: 2
Page: 1-3
PDF size: 103.78 Kb.
Text Extraction
No abstract.REFERENCES
Logunov DY, Dolzhikova IV, Shcheblyakov DV, Tukhvatulin AI, Zubkova OV, Dzharullaeva AS, et al. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia. Lancet. 2021;397(10275):671–81. doi: https:// doi.org/10.1016/s0140-6736(21)00234-8